Biomimetic peroxisome targets myocardial injury and promotes heart repair and regeneration

IF 12.9 1区 医学 Q1 ENGINEERING, BIOMEDICAL Biomaterials Pub Date : 2025-02-25 DOI:10.1016/j.biomaterials.2025.123214
Ning Zhang , Menghan Gao , Xiaolong Hu , Peng Wang , Yuan Cheng , Hui Wei , Guosheng Fu , Junbo Ge , Hongjun Li , Wenbin Zhang , Binquan Zhou
{"title":"Biomimetic peroxisome targets myocardial injury and promotes heart repair and regeneration","authors":"Ning Zhang ,&nbsp;Menghan Gao ,&nbsp;Xiaolong Hu ,&nbsp;Peng Wang ,&nbsp;Yuan Cheng ,&nbsp;Hui Wei ,&nbsp;Guosheng Fu ,&nbsp;Junbo Ge ,&nbsp;Hongjun Li ,&nbsp;Wenbin Zhang ,&nbsp;Binquan Zhou","doi":"10.1016/j.biomaterials.2025.123214","DOIUrl":null,"url":null,"abstract":"<div><div>Heart ischemic injury predominately causes mitochondrial dysfunction, leading to the accumulation of ROS and lactate. The ROS-associated DNA damage response (DDR) contributes to myocardial cell cycle arrest and the inhibition of proliferation, while lactate accumulation is often accompanied by a high risk of acute death. In this study, to restore myocardial metabolism and regenerate the heart, we established a biomimetic peroxisome by loading the Mn<sub>3</sub>O<sub>4</sub> nanozyme into mesenchymal stem cell-derived extracellular vesicles (MSC-EV (Mn@EV)). This setup mimics the peroxidases of peroxisome to catalyze ROS, and inhibit DDR. Next, the Mn@EV was immobilized with lactate oxidase (LOX) after encompassed platelet membrane to obtain biomimetic peroxisome (Mn@LPEV). This mimics the substrate-oxidizing function to detoxify lactate and prevent death. Supported by its biomimetic and lactate-response delivery system, our biomimetic peroxisome effectively targeted deep tissues in the hearts of I/R mice, achieving a 4-fold increase in targeting compared with control vesicles. It maintained myocardial redox homeostasis by scavenging ROS and lactate, inhibiting DDR pathway, promoting myocardial regeneration, reducing acute mortality and fibrosis remodeling, accelerating immunomodulation and angiogenesis, and significantly protecting heart function.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"319 ","pages":"Article 123214"},"PeriodicalIF":12.9000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0142961225001334","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Heart ischemic injury predominately causes mitochondrial dysfunction, leading to the accumulation of ROS and lactate. The ROS-associated DNA damage response (DDR) contributes to myocardial cell cycle arrest and the inhibition of proliferation, while lactate accumulation is often accompanied by a high risk of acute death. In this study, to restore myocardial metabolism and regenerate the heart, we established a biomimetic peroxisome by loading the Mn3O4 nanozyme into mesenchymal stem cell-derived extracellular vesicles (MSC-EV (Mn@EV)). This setup mimics the peroxidases of peroxisome to catalyze ROS, and inhibit DDR. Next, the Mn@EV was immobilized with lactate oxidase (LOX) after encompassed platelet membrane to obtain biomimetic peroxisome (Mn@LPEV). This mimics the substrate-oxidizing function to detoxify lactate and prevent death. Supported by its biomimetic and lactate-response delivery system, our biomimetic peroxisome effectively targeted deep tissues in the hearts of I/R mice, achieving a 4-fold increase in targeting compared with control vesicles. It maintained myocardial redox homeostasis by scavenging ROS and lactate, inhibiting DDR pathway, promoting myocardial regeneration, reducing acute mortality and fibrosis remodeling, accelerating immunomodulation and angiogenesis, and significantly protecting heart function.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
仿生过氧化物酶体靶向心肌损伤,促进心脏修复和再生
心脏缺血损伤主要引起线粒体功能障碍,导致ROS和乳酸的积累。ros相关的DNA损伤反应(DDR)有助于心肌细胞周期阻滞和增殖抑制,而乳酸积累往往伴随着急性死亡的高风险。在这项研究中,为了恢复心肌代谢和再生心脏,我们通过将Mn3O4纳米酶装载到间充质干细胞来源的细胞外囊泡(MSC-EV (Mn@EV))中建立了一个仿生过氧化物酶体。这种设置模拟过氧化物酶体的过氧化物酶来催化ROS,并抑制DDR。接下来,将包裹血小板膜后的Mn@EV用乳酸氧化酶(LOX)固定,得到仿生过氧化物酶体(Mn@LPEV)。这模仿底物氧化功能来解毒乳酸和防止死亡。在其仿生和乳酸反应递送系统的支持下,我们的仿生过氧化物酶体有效地靶向I/R小鼠心脏深部组织,与对照囊泡相比,靶向性提高了4倍。通过清除ROS和乳酸,抑制DDR通路,促进心肌再生,降低急性死亡率和纤维化重构,加速免疫调节和血管生成,显著保护心功能,维持心肌氧化还原稳态。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Biomaterials
Biomaterials 工程技术-材料科学:生物材料
CiteScore
26.00
自引率
2.90%
发文量
565
审稿时长
46 days
期刊介绍: Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.
期刊最新文献
Janus silk-based patch with temporary adhesion for inflammatory mediators removal in corneal alkali burn treatment. A nanosystem targeting genomic instability and mitochondrial damage to stimulate STING pathway for synergistic immunotherapy for advanced prostate cancer. The increasing N2/N1 neutrophil ratio over time in human fracture hematoma indicates a transition from inflammation to regeneration. Genetically engineered cellular membrane-camouflaged nanoparticles amplify immune response against recurrent metastatic triple-negative breast cancer. PRP-driven biomimetic liver tissue engineering: A cost-effective platform for high-efficiency expansion of mouse primary hepatocytes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1